Jia‐Bing Wang

Fujian Medical University

Papers

1

Total Citations

6

H-Index

1

About

Jia-Bing Wang is a prominent surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment. His major contributions center on comparing robotic and laparoscopic distal gastrectomy, with his landmark 2020 randomized controlled trial providing critical evidence on the safety and efficacy of robotic-assisted surgery. This work, cited 6 times, has helped clarify the role of robotics in gastric cancer management, addressing key questions about operative outcomes and recovery. Wang’s research has significant clinical impact, guiding surgeons in selecting optimal approaches for patients. Beyond this trial, he has contributed to studies on surgical innovations and perioperative care, earning recognition as a leading voice in gastrointestinal oncology. His findings are frequently referenced in surgical guidelines and have influenced practice patterns, particularly in Asia where gastric cancer incidence is high. Wang’s dedication to rigorous comparative effectiveness research continues to shape the evolution of gastric cancer surgery, balancing technological advancement with patient-centered outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
114O Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Fujian Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago